Group News

NYP/Columbia was among the first to offer patients access to Heartmate 3, the newest LVAD technology, in a clinical trial testing it against current standard of treatment, the Heart Mate II. In a randomized study reported in New England Journal of Medicine and presented at American Heart Association in November 2016, lead investigator Yoshifumi Naka, MD, PhD, reported fewer complications with the Heartmate 3, noting a marked improvement over Heartmate II.
Read More >
What's New in the Department of Surgery

Mini-Sternotomy for a Tortuous Aortic Aneurysm

Read More >
What's New in the Department of Surgery

Pulmonary Vein Stenosis (PVS)

Read More >
The interventional cardiologist or surgeon places the artificial valve in the diseased valve and inflates the balloon
(TAVR)—a minimally invasive method of replacing damaged aortic valves.
Read More >
The Hypertrophic Cardiomyopathy Center is a multidisciplinary program that offers patients essentially every treatment option.
Read More >

Pages